An experimental drug that can virtually halt the deadly spread of breast cancer has been tested by scientists.
Researchers are now working with a biotechnology company to prepare the compound for patient trials.
The new research builds on previous studies of a gene called Bc13 that appears to play a critical role in the spread of breast cancer.
Scientists at Cardiff University conducted computer simulations to work out how Bc13 functioned and then blocked it.
In tests on mice, the researchers first deleted the gene and then explored ways of inhibiting it with a drug.They found the right candidate compound by screening a library of chemicals until one was found that could target Bc13.
When mice with metastatic breast cancer were treated with the compound, the spread of tumours to the lungs and other parts of the body was dramatically reduced.
More top news
Tom Bradby will play host to the leaders of the three main parties, as well as the biggest names from the worlds of arts and culture.
One of the greatest sporting events on earth gets underway this week as the Ryder Cup heads to Scotland, here's everything you need to know
A toddler was in need of an unusual rescue after she got a kettle stuck on her head while playing at home in Chile.